Stock analysts at Evercore ISI initiated coverage on shares of Humana Inc. (NYSE:HUM) in a report issued on Thursday. The brokerage set a “buy” rating on the insurance provider’s stock.
HUM has been the topic of a number of other reports. JPMorgan Chase & Co. cut shares of Humana from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $196.00 to $150.00 in a research note on Friday, July 8th. Zacks Investment Research lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday. Argus reaffirmed a “hold” rating on shares of Humana in a report on Tuesday, August 23rd. Wolfe Research raised shares of Humana to an “outperform” rating and set a $192.00 target price on the stock in a report on Thursday, July 21st. Finally, Credit Suisse Group AG upped their target price on shares of Humana from $160.00 to $170.00 and gave the stock a “neutral” rating in a report on Thursday, July 21st. Six equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $201.00.
Shares of Humana (NYSE:HUM) traded up 0.08% during mid-day trading on Thursday, reaching $175.99. 452,954 shares of the company’s stock were exchanged. The company has a 50 day moving average price of $177.35 and a 200 day moving average price of $176.67. Humana has a 52-week low of $150.00 and a 52-week high of $191.65. The firm has a market cap of $26.23 billion, a P/E ratio of 27.04 and a beta of 0.91.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/humana-inc-hum-now-covered-by-analysts-at-evercore-isi.html
Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, beating the Zacks’ consensus estimate of $2.23 by $0.07. The company had revenue of $14 billion for the quarter, compared to analysts’ expectations of $13.59 billion. Humana had a net margin of 1.76% and a return on equity of 11.11%. Humana’s revenue was up 2.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.67 EPS. Analysts forecast that Humana will post $9.26 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be given a dividend of $0.29 per share. The ex-dividend date of this dividend is Tuesday, October 11th. This represents a $1.16 annualized dividend and a yield of 0.66%. Humana’s payout ratio is currently 18.18%.
A number of large investors have recently made changes to their positions in the stock. Rehmann Capital Advisory Group boosted its stake in shares of Humana by 0.4% in the first quarter. Rehmann Capital Advisory Group now owns 1,506 shares of the insurance provider’s stock valued at $276,000 after buying an additional 6 shares during the last quarter. First Republic Investment Management Inc. boosted its stake in shares of Humana by 1.8% in the first quarter. First Republic Investment Management Inc. now owns 1,145 shares of the insurance provider’s stock valued at $209,000 after buying an additional 20 shares during the last quarter. Northwestern Mutual Investment Management Company LLC boosted its stake in shares of Humana by 0.4% in the second quarter. Northwestern Mutual Investment Management Company LLC now owns 5,684 shares of the insurance provider’s stock valued at $1,022,000 after buying an additional 22 shares during the last quarter. Fifth Third Bancorp boosted its stake in shares of Humana by 0.5% in the second quarter. Fifth Third Bancorp now owns 4,547 shares of the insurance provider’s stock valued at $818,000 after buying an additional 23 shares during the last quarter. Finally, Savant Capital LLC boosted its stake in shares of Humana by 1.3% in the second quarter. Savant Capital LLC now owns 2,380 shares of the insurance provider’s stock valued at $428,000 after buying an additional 30 shares during the last quarter. 93.24% of the stock is owned by institutional investors and hedge funds.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Humana Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.